Skip to main content
. Author manuscript; available in PMC: 2016 Jun 15.
Published in final edited form as: Cancer. 2015 Mar 13;121(12):1957–1965. doi: 10.1002/cncr.29303

Table 3.

Multivariable analysis for QMSP gene combinations in association with clinical outcomes

Factors LRFS RFS OS
HR (95% CI) P-value HR (95% CI) P-value HR (95% CI) P-value
EDNRB/HOXA9 imprint Positive vs negative 3.31(1.30, 8.46) 0.012 2.74(0.90, 8.33) 0.075 5.78(0.75,44.7) 0.093
Differentiation Poor vs moderate, well 1.04(0.36, 3.00) 0.95 1.93(0.81, 4.57) 0.14 3.68(1.15, 11.7) 0.028
pTNM Stage III, IV vs I, II 0.72(0.24, 2.21) 0.57 2.12(0.73, 6.18) 0.17 4.72(0.91, 24.6) 0.065